Nova Diagnostics Labs LLC
Nova Diagnostics Labs LLC was paid $553K by Medicaid between Jan 2022 and Dec 2023, across 25 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 59% of everything it billed.
33Billing provider infoNOVA DIAGNOSTICS LABS LLC
LOMBARD, IL 60148
LOMBARD, IL 60148
33aNPI1053906636assigned 03/04/2021
33bProvider typeClinical Laboratory Director (Non-physician)
28Total paid$553K
24GClaims14,616
24DCodes billed25
24AFirst – last monthJan 2022 – Dec 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 8,051 | $321K | |
| 2023 | 6,565 | $231K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 59% | 4,434 | 1,969 | $329K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19% | 4,496 | 1,995 | $104K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 17% | 3,706 | 1,956 | $91K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.9% | 790 | 652 | $27K |
| 87641 | <1% | 69 | 68 | $770.27 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 106 | 105 | $385.26 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 32 | 32 | $97.93 |
| 87634 | <1% | 32 | 32 | $79.72 | |
| 87631 | <1% | 32 | 32 | $78.08 | |
| 87556 | <1% | 32 | 32 | $42.60 | |
| 87481 | <1% | 106 | 105 | $39.85 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 104 | 103 | $39.85 |
13 more codes
| 87486 | <1% | 32 | $39.85 | |
| 87581 | <1% | 32 | $39.85 | |
| 87498 | <1% | 32 | $39.85 | |
| 87532 | <1% | 32 | $39.85 | |
| 87496 | <1% | 32 | $39.85 | |
| 87541 | <1% | 32 | $39.85 | |
| 87640 | <1% | 106 | $39.85 | |
| 87653 | <1% | 106 | $39.00 | |
| 87503 | <1% | 32 | $28.89 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 70 | $0.00 |
| 86413 | 0% | 31 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 70 | $0.00 |
| 87500 | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAHEEM, ABDUL (OWNER)